兴齐眼药
(300573)
| 流通市值：92.04亿 | | | 总市值：120.10亿 |
| 流通股本：2.72亿 | | | 总股本：3.55亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,237,615,141 | 1,400,873,956.41 | 683,337,441.58 | 2,472,852,236.79 |
| 营业收入 | 2,237,615,141 | 1,400,873,956.41 | 683,337,441.58 | 2,472,852,236.79 |
| 二、营业总成本 | 1,420,647,591.28 | 921,296,880.83 | 456,989,442.88 | 1,667,470,697.01 |
| 营业成本 | 386,897,223.17 | 248,077,845.85 | 122,644,319.06 | 465,962,118.19 |
| 税金及附加 | 30,932,312.62 | 19,330,670.08 | 9,244,272.6 | 32,831,651.69 |
| 销售费用 | 647,237,182.59 | 413,478,661.58 | 199,598,174.58 | 763,972,611.16 |
| 管理费用 | 124,316,644.37 | 80,794,547.85 | 41,752,758.11 | 174,547,138.04 |
| 研发费用 | 232,818,102.9 | 161,302,852.97 | 84,474,178.33 | 225,910,095.09 |
| 财务费用 | -1,553,874.37 | -1,687,697.5 | -724,259.8 | 4,247,082.84 |
| 其中:利息费用 | 1,122,944.83 | 676,984.56 | 481,320.49 | 4,435,786.8 |
| 其中:利息收入 | 1,283,326.89 | 861,905.81 | 408,353.82 | 2,252,622.99 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 4,525,556.52 | 5,126,142.18 | - | - |
| 资产处置收益 | -1,452.35 | 7,973.32 | - | 52,536.38 |
| 资产减值损失(新) | -1,375,230.49 | -509,433.41 | -30,626.73 | -15,176,291.68 |
| 信用减值损失(新) | -3,369,217.06 | -1,288,063.05 | -526,819.54 | -2,174,108.55 |
| 其他收益 | 17,060,042.4 | 12,101,457.62 | 6,787,149.17 | 34,138,553.38 |
| 四、营业利润 | 833,807,248.74 | 495,015,152.24 | 232,577,701.6 | 822,222,229.31 |
| 加:营业外收入 | 13,556 | 10,000 | 10,000 | 517,251.63 |
| 减:营业外支出 | 26,774,185.65 | 12,726,436.78 | 2,468,274.91 | 22,463,807.22 |
| 五、利润总额 | 807,046,619.09 | 482,298,715.46 | 230,119,426.69 | 800,275,673.72 |
| 减:所得税费用 | 101,940,762.11 | 51,894,422.1 | 23,705,152.2 | 104,420,077.47 |
| 六、净利润 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 |
| 扣除非经常损益后的净利润 | 715,811,882.36 | 431,589,421.95 | 206,363,102.71 | 697,046,957.34 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.98 | 1.2 | 0.84 | 2.83 |
| (二)稀释每股收益 | 1.97 | 1.2 | 0.84 | 2.83 |
| 八、其他综合收益 | - | - | - | 1,416,666.67 |
| 归属于母公司股东的其他综合收益 | - | - | - | 1,416,666.67 |
| 九、综合收益总额 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 697,272,262.92 |
| 归属于母公司股东的综合收益总额 | 705,105,856.98 | 430,404,293.36 | 206,414,274.49 | 697,272,262.92 |
| 公告日期 | 2026-10-29 | 2026-08-28 | 2026-04-28 | 2026-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |